Physician profile
Kunal Walia
NPI 1215121637
$15,770.90
in general payments reported to CMS, 2019-2025
10 companies · $7,440 in 2025
The $7,440 reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $693 · 2021: $2,740 · 2022: $2,935 · 2023: $66.37 · 2024: $1,527 · 2025: $7,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,300 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Food and Beverage: $121 · Education: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,299.75 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Food and Beverage | $120.74 |
| Education | $113.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Envista Holdings Corporation | $7,339.54 | 2024-2025 | Education, Maxcem Elite |
| Nobel Biocare USA | $5,362.72 | 2019-2023 | Nobelactive |
| Septodont INC. | $1,500.00 | 2024 | Biodentine |
| Kavo Dental Technologies LLC | $960.00 | 2021 | |
| Dentsply Sirona INC | $267.87 | 2019-2025 | Cavitron |
| Straumann USA LLC | $116.75 | 2020-2025 | |
| Henry Schein, INC. | $98.01 | 2022 | |
| Kerr Corporation | $64.51 | 2019 | |
| Implant Direct Sybron International LLC | $47.82 | 2019 | |
| Voco America INC. | $13.68 | 2024 | Admira Fusion X-Tra, Profluorid L, Meron Plus Qm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Walia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.